Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- AVONELLE-X
A clinical trial to look at the long-term safety of faricimab in patients with neovascular age-related macular degeneration (nAMD, also known as wet AMD)
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
Eye Disorder Neovascular Age-related Macular Degeneration Wet Age-Related Macular Degeneration Age-Related Macular Degeneration
- Results
-
Download -
Study results
LPS GR42691 AVONELLE-X Final Results July 2025 English
(PDF, 1.1 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Argentina Spanish
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Australia English
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Austria German
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Belgium Dutch
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Belgium German
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Brazil Portuguese
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Bulgarian
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Canada English
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Catalonia Spanish
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Danish
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 France French
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Germany German
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Hungarian
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Israel Russian
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Japanese
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Korean
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Kurdish
(PDF, 0.7 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Mexico Spanish
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 USA Spanish
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 UK English
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Turkish
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Thai
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Switzerland Italian
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Switzerland German
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Switzerland French
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Spain Spanish
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Russia Russian
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Portugal Portuguese
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Polish
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Netherlands Dutch
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Malay
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Canada French
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Israel Hebrew
(PDF, 0.7 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 LATAM Spanish
(PDF, 0.5 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Italy Italian
(PDF, 0.6 MB)
LPS GR42691 AVONELLE-X Final Results July 2025 Singapore Chinese
(PDF, 0.7 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com